Genertec Universal Medical Group Company Limited
HKEX:2666.HK
4.41 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 13,650.203 | 11,565.809 | 9,566.906 | 8,243.234 | 6,746.812 | 4,295.013 | 3,423.98 | 2,708.715 | 2,195.202 | 1,556.761 | 984.02 |
| Cost of Revenue
| 9,078.344 | 7,426.151 | 5,714.834 | 4,967.263 | 3,636.505 | 1,705.442 | 1,244.64 | 965.97 | 884.851 | 619.594 | 0 |
| Gross Profit
| 4,571.859 | 4,139.658 | 3,852.072 | 3,275.971 | 3,110.307 | 2,589.571 | 2,179.34 | 1,742.745 | 1,310.351 | 937.167 | 984.02 |
| Gross Profit Ratio
| 0.335 | 0.358 | 0.403 | 0.397 | 0.461 | 0.603 | 0.636 | 0.643 | 0.597 | 0.602 | 1 |
| Reseach & Development Expenses
| 35.875 | 48.073 | 25.844 | 16.629 | 13.825 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1,168.436 | 899.168 | 739.754 | 613.868 | 441.408 | 244.35 | 189.62 | 277.232 | 246.496 | 190.614 | 143.458 |
| Selling & Marketing Expenses
| 397.168 | 441.603 | 462.005 | 380.39 | 404.589 | 387.251 | 334.203 | 277.251 | 213.926 | 126.295 | 106.874 |
| SG&A
| 1,565.604 | 1,340.771 | 1,201.759 | 994.258 | 845.997 | 631.601 | 523.823 | 554.483 | 460.422 | 316.909 | 261.269 |
| Other Expenses
| -512.668 | -530.398 | -279.553 | -109.873 | -94.135 | -104.661 | -20.447 | -3.018 | -3.44 | -16.414 | 0 |
| Operating Expenses
| 1,340.027 | 8,861.523 | 6,875.098 | 5,878.22 | 4,534.953 | 2,435.974 | 1,847.519 | 1,502.77 | 1,294.928 | 945.679 | 565.676 |
| Operating Income
| 2,775.102 | 2,798.887 | 2,650.313 | 2,281.713 | 2,264.31 | 1,957.97 | 1,655.517 | 1,188.262 | 849.929 | 620.258 | 374.132 |
| Operating Income Ratio
| 0.203 | 0.242 | 0.277 | 0.277 | 0.336 | 0.456 | 0.484 | 0.439 | 0.387 | 0.398 | 0.38 |
| Total Other Income Expenses Net
| 91.111 | -94.601 | 41.495 | 83.301 | -52.451 | -98.931 | -79.056 | 17.683 | 50.345 | -9.176 | 44.212 |
| Income Before Tax
| 2,866.213 | 2,704.286 | 2,691.808 | 2,365.014 | 2,211.859 | 1,859.039 | 1,576.461 | 1,205.945 | 900.274 | 611.082 | 418.344 |
| Income Before Tax Ratio
| 0.21 | 0.234 | 0.281 | 0.287 | 0.328 | 0.433 | 0.46 | 0.445 | 0.41 | 0.393 | 0.425 |
| Income Tax Expense
| 667.141 | 616.759 | 661.339 | 551.104 | 577.467 | 508.375 | 427.782 | 333.635 | 241.748 | 154.444 | 105.606 |
| Net Income
| 2,110.337 | 1,959.82 | 1,947.73 | 1,747.137 | 1,588.336 | 1,352.173 | 1,148.658 | 872.31 | 658.526 | 456.638 | 312.738 |
| Net Income Ratio
| 0.155 | 0.169 | 0.204 | 0.212 | 0.235 | 0.315 | 0.335 | 0.322 | 0.3 | 0.293 | 0.318 |
| EPS
| 1.07 | 1 | 0.99 | 0.96 | 0.87 | 0.79 | 0.67 | 0.51 | 0.44 | 0.51 | 0.51 |
| EPS Diluted
| 0.99 | 0.93 | 0.91 | 0.96 | 0.87 | 0.79 | 0.67 | 0.51 | 0.44 | 0.51 | 0.51 |
| EBITDA
| 3,318.338 | -292.116 | -153.741 | -83.072 | -198.107 | -97.422 | -79.077 | 17.683 | 50.345 | -9.176 | 44.212 |
| EBITDA Ratio
| 0.243 | -0.025 | -0.016 | -0.01 | -0.029 | -0.023 | -0.023 | 0.007 | 0.023 | -0.006 | 0.045 |